BioStem Technologies, Inc.

0JQ.F·Frankfurt·Healthcare
Compare
1.7600−0.0580 (−3.19%)today
As of Oct 16, 3:25 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.8180
Open1.7620
Day range1.76001.7620
52-week range1.76004.3850
Off day high−0.11%
Off 52-week high−59.86%
Volume628
Avg. volume (3M)13.00
Market cap32.86M
EPS (TTM)0.6800
Forward P/E—
P/E ratio (TTM)2.59
Dividend yield—
Beta (5Y)0.50
Shares outstanding18.67M
Short interest—
Earnings dateAug 12, 2026 (est.)
Analyst target—
Profit margin−81.80%

Against its peers

Compare in full ›
0JQ.F CELU CLGN MDXG SVA.TO HUMA
Market cap 32.86M 40.56M 6.85M 646.49M 43.43M 119.18M
P/E (TTM) 2.6 — — 110.8 11.5 —
Forward P/E — -2.2 -9.3 32.4 -3.8 -1.7
Price/book 1.3 -1.0 1.8 3.0 -1.8 3.8
Dividend yield — — — — — —
1-year change −40.07% −32.83% −85.44% −30.04% −33.33% −76.30%
Today −3.19% −6.02% −1.49% −5.34% 0.00% −2.39%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to 0JQ.F's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Celularity Inc.CELU · Biotechnology 40.56M 1.2500 −6.02%
CollPlant Biotechnologies Ltd.CLGN · Biotechnology 6.85M 3.6250 −1.49%
MiMedx Group, Inc.MDXG · Biotechnology 646.49M 4.4300 −5.34%
Sernova Biotherapeutics IncSVA.TO · Biotechnology 43.43M 0.1150 0.00%
Humacyte, Inc.HUMA · Biotechnology 119.18M 0.4290 −2.39%
Creative Medical Technology Holdings, Inc.CELZ · Biotechnology 5.63M 0.7410 −9.39%
ABVC BioPharma, Inc.ABVC · Biotechnology 24.50M 0.9179 −1.57%
BioCardia, Inc.BCDA · Biotechnology 13.93M 0.9201 −5.20%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All 0JQ.F news ›
Stock Titan·

[EFFECT] BioStem Technologies, Inc. SEC Filing

BioStem Technologies, Inc. SEC Filing (Oct 13, 2026) Stock Titan [EFFECT] BioStem Technologies, Inc. SEC Filing Sentiment and the balance of points Rhea-AI Sentiment reads the wording of the document, how positive or negative its language…

The Globe and Mail·Negative

BioStem Technologies Completes $3 Million Private Placement Financing

BioStem Technologies ( (BSEM) ) has provided an update. The most recent analyst rating on (BSEM) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on BioStem Technologies stock, see the BSEM Stock Forecast…

From articles in the 4Search news index.

In the news

8mentions in 30 days
8with it in the headline
Mixedsentiment

Mentioned with

Biostem8Biostem Technologies, Inc.6Biostem Technologies Inc.5H.c. Wainwright & Co.4Leerink Partners4Wallachbeth Capital Llc4American Association of Tissue Banks3Jefferies3

People in the coverage

Jason Matuszewski7Philip Trip Taylor6Clarix5Gilmartin5Piper Sandler5J.p. Morgan4

Themes

Announces5Bsem5Healthcare5Biotechnology4Million4Placement4Private4Biotech3

Most coverage from

  1. seekingalpha.com2
  2. theglobeandmail.com2
  3. globenewswire.com1
  4. manilatimes.net1
  5. stocktitan.net1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.